May 14, 2026
Wellgistics Health Inc.
ISIN: US9495031067
Wellgistics Health Accelerates Digital Health Expansion of its Newly Announced RPM, RTM and CCM Pilot with Planned Acquisition of WellCare Today and its Proprietary Samsung Galaxy Watch Care Monitoring Program
Highlights: - WellCare Today brings established RPM, RTM and CCM infrastructure with wearable technology integrations and connected monitoring solutions- Combination expected to integrate Wellgistics Health recently announced MSO initiative with Kare...
Read more >>Wellgistics Health Announces Pilot MSO Collaboration with Kare PharmTech Targeting $14 Billion U.S. Market for CCM and RPM Services
Highlights: - According to third-party industry reports, the U.S. RPM market is currently $14 Billion alone and expected to reach approximately $29 Billion by 2030, representing a 12.6% CAGR, as healthcare providers continue shifting toward value-based and home-based care models¹ - Pilot initiative launched across multiple provider offices focused on chronic care...
Read more >Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives
- Joint venture executed combining Wellgistics Hub and KareRx Hub technology and operations- Integrated platform accelerates pharmaceutical access, fulfillment, and commercialization- Combined ecosystem provides potential reach to an estimated 200,000+ patient lives across pharmaceutical and provider networks TAMPA, FL / ACCESS Newswire / April 14, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX)...
Read more >Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc.
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders TAMPA, FL / ACCESS Newswire / March 23, 2026 / Wellgistics Health, Inc. (“Wellgistics” or the “Company”) (NASDAQ:WGRX) today announced that it has entered into...
Read more >